IK1: The long and the short QT of it

Heart Rhythm

Volumn 3, Issue 3, 2006, Pages 336-338

  Gross, Gil J ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; KCNJ2 PROTEIN, HUMAN;

EDITORIAL; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART REPOLARIZATION; HUMAN; INCIDENCE; LONG QT SYNDROME; MEMBRANE STEADY POTENTIAL; MISSENSE MUTATION; POTASSIUM CURRENT; PREVALENCE; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH; ANDERSEN SYNDROME; GENETICS; MUTATION; NOTE; PATHOPHYSIOLOGY; PHENOTYPE;

ANDERSEN SYNDROME; ARRHYTHMIA; HUMANS; MUTATION; PHENOTYPE; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 33144478924     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2005.12.026     Document Type: Editorial

References (33)

1. Ks potassium channel Nature 384 1996 80-83
2. Ks cardiac potassium current Nature 384 1996 78-80
3. Kr potassium channel Cell 81 1995 299-307
4. M.E. Curran I. Splawski K.W. Timothy G.M. Vincent E.D. Green M.T. Keating A molecular basis for cardiac arrhythmia HERG mutations cause long QT syndrome Cell 80 1995 795-803
5. D.M. Roden Drug-induced prolongation of the QT interval N Engl J Med 350 2004 1013-1022
6. P.T. Fitzgerald M.J. Ackerman Drug-induced torsades de pointes the evolving role of pharmacogenetics Heart Rhythm 2 2005 S30-S37
7. K1 blockade a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate Circulation 87 1993 1979-1989
8. K1 blockade is a potentially useful antiarrhythmic mechanism Cardiovasc Res 28 1994 421
9. K1 blockade is unlikely to be a useful antiarrhythmic mechanism Cardiovasc Res 28 1994 420
10. N.M. Plaster R. Tawil M. Tristani-Firouzi S. Canün S. Bendahhou A. Tsunoda M.R. Donaldson S.T. Iannaccone E. Brunt R. Barohn J. Clark F. Deymeer A.L. George Jr F.A. Fish A. Hahn A. Nitu C. Ozdemir P. Serdaroglu S.H. Subramony G. Wolfe Y.H. Fu L.J. Ptácek Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome Cell 105 2001 511-519
11. E.D. Andersen P.A. Krasilnikoff H. Overvad Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand 60 1971 559-564
12. R. Tawil L.J. Ptácek S.G. Pavlakis D.C. DeVivo A.S. Penn C. Ozdemir R.C. Griggs Andersen's syndrome potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features Ann Neurol 35 1994 326-330
13. M.R. Donaldson G. Yoon Y.H. Fu L.J. Ptácek Andersen-Tawil syndrome a model of clinical variability, pleiotropy, and genetic heterogeneity Ann Med 36 suppl 1 2004 92-97
14. G. Andelfinger A.R. Tapper R.C. Welch C.G. Vanoye A.L. George Jr D.W. Benson KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes Am J Hum Genet 71 2002 663-668
15. M. Tristani-Firouzi J.L. Jensen M.R. Donaldson V. Sansone G. Meola A. Hahn S. Bendahhou H. Kwiecinski A. Fidzianska N. Plaster Y.H. Fu L.J. Ptácek R. Tawil Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) J Clin Invest 110 2002 38138-8
16. Y. Hosaka H. Hanawa T. Washizuka M. Chinushi F. Yamashita T. Yoshida S. Komura H. Watanabe Y. Aizawa Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome J Mol Cell Cardiol 35 2003 409-415
17. S. Bendahhou E. Fournier D. Sternberg G. Bassez A. Furby C. Sereni M.R. Donaldson M.M. Larroque B. Fontaine J. Barhanin In vivo and in vitro functional characterization of Andersen's syndrome mutations J Physiol 565 2005 731-741
18. R. Preisig-Müller G. Schlichthörl T. Goerge S. Heinen A. Brüggemann S. Rajan C. Derst R.W. Veh J. Daut Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome Proc Natl Acad Sci U S A 99 2002 7774-7779
19. J. Miake E. Marbán H.B. Nuss Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression J Clin Invest 111 2003 1529-1536
20. F. Gaita C. Giustetto F. Bianchi C. Wolpert R. Schimpf R. Riccardi S. Grossi E. Richiardi M. Borggrefe Short QT Syndrome a familial cause of sudden death Circulation 108 2003 965-970
21. R. Schimpf C. Wolpert F. Gaita C. Giustetto M. Borggrefe Short QT syndrome Cardiovasc Res 67 2005 357-366
22. S.G. Priori S.V. Pandit I. Rivolta O. Berenfeld E. Ronchetti A. Dhamoon C. Napolitano J. Anumonwo M.R. di Barletta S. Gudapakkam G. Bosi M. Stramba-Badiale J. Jalife A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene Circ Res 96 2005 800-707
23. M. Borggrefe C. Wolpert C. Antzelevitch C. Veltmann C. Giustetto F. Gaita R. Schimpf Short QT syndrome. Genotype-phenotype correlations J Electrocardiol 38 2005 75-80
24. E. Schulze-Bahr Short QT syndrome or Andersen syndrome yin and yang of Kir2.1 channel dysfunction Circ Res 96 2005 703-704
25. L. Zhang D.W. Benson M. Tristani-Firouzi L.J. Ptácek R. Tawil P.J. Schwartz A.L. George M. Horie G. Andelfinger G.L. Snow Y.H. Fu M.J. Ackerman G.M. Vincent Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations characteristic T-U-wave patterns predict the KCNJ2 genotype Circulation 111 2005 2720-2726
26. 2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome Neurology 60 2003 1811-1816
27. N.P. Davies P. Imbrici D. Fialho C. Herd L.G. Bilsland A. Weber R. Mueller D. Hilton-Jones J. Ealing B.R. Boothman P. Giunti L.M. Parsons M. Thomas A.Y. Manzur K. Jurkat-Rott F. Lehmann-Horn P.F. Chinnery M. Rose D.M. Kullmann M.G. Hanna Andersen-Tawil syndrome new potassium channel mutations and possible phenotypic variation Neurology 65 2005 1083-1089
28. S. Bendahhou M.R. Donaldson N.M. Plaster M. Tristani-Firouzi Y.H. Fu L.J. Ptácek Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome J Biol Chem 278 2003 51779-51785
29. M. Tsuboi C. Antzelevitch Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7) Heart Rhythm 3 2006 328-335
30. to1 in myocytes isolated from the human right ventricle Am J Physiol 275 1998 H369-H377
31. D.W. Liu G.A. Gintant C. Antzelevitch Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle Circ Res 72 1993 671-687
32. M. Xia Q. Jin S. Bendahhou Y. He M.M. Larroque Y. Chen Q. Zhou Y. Yang Y. Liu B. Liu Q. Zhu Y. Zhou J. Lin B. Liang L. Li X. Dong Z. Pan R. Wang H. Wan W. Qiu W. Xu P. Eurlings J. Barhanin Y. Chen A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation Biochem Biophys Res Commun 332 2005 1012-1019
33. K1 in the mouse heart leads to multiple abnormalities of cardiac excitability Am J Physiol Heart Circ Physiol 287 2004 H2790-H2802